USANA Health Sciences’ 2026 EPS Forecast Rises to $2.00 as Shares Fall 41%
Over the past two months, analysts have raised USANA Health Sciences’ 2026 EPS estimates from $1.90 to $2.00, reflecting a 5.3% upward revision, while shares have declined 41.2% over six months. The company beat earnings estimates in three of the last four quarters with an average surprise of 21.9%.
1. Earnings Estimate Revision
Analysts increased USANA Health Sciences’ 2026 EPS forecast from $1.90 to $2.00 over the past 60 days, representing a 5.3% upgrade. This adjustment reflects growing confidence in the company’s revenue outlook and profitability prospects for the upcoming fiscal year.
2. Stock Performance and Rankings
USANA shares have dropped 41.2% over the past six months, contrasting industry growth. The company beat earnings estimates in three of the trailing four quarters, delivering an average surprise of 21.9%, and currently holds a Zacks Rank #1, signaling strong fundamentals among analysts.